AstraZeneca PLC (AZN)
Data as of September 4, 2026 · Drug Manufacturers - General
Stockbruh grade: Mixed 3/5 metrics rated Sunny
What does AstraZeneca PLC do?
AstraZeneca, a biopharmaceutical company headquartered in Cambridge, UK, focuses on developing and commercializing prescription medicines. Their diverse range of products includes treatments for oncology, cardiovascular diseases, respiratory conditions, rare diseases, and even COVID-19. With collaborations with leading pharmaceutical companies and a global presence, AstraZeneca is committed to improving healthcare worldwide. 💊🌍.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛅ Moderate | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ⛈️ Weak | Balance sheet strength |
| Price | $164.77 | Market Cap | — |
| Exchange | NASDAQ Global Select | | |
Plain-English Analysis
What's it worth?
Performance has been moderate. Sign up free to see Stockbruh's full valuation analysis including price ratios and plain-English commentary.
How the business works
AstraZeneca, a biopharmaceutical company headquartered in Cambridge, UK, focuses on developing and commercializing prescription medicines. Their diverse range of products includes treatments for oncology, cardiovascular diseases, respiratory conditions, rare diseases, and even COVID-19. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Revenue and earnings are trending upward — AstraZeneca PLC appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.